NASDAQ:ATXI Avenue Therapeutics 5/15/2024 Earnings Report $0.24 0.00 (-0.08%) As of 06/26/2025 02:20 PM Eastern ProfileEarnings History Avenue Therapeutics EPS ResultsActual EPS-$15.40Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAvenue Therapeutics Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAvenue Therapeutics Announcement DetailsQuarterDate5/15/2024TimeN/AConference Call DateN/AConference Call TimeN/AUpcoming EarningsAvenue Therapeutics' next earnings date is estimated for Thursday, August 7, 2025, based on past reporting schedules. Conference Call ResourcesEarnings HistoryCompany Profile Avenue Therapeutics Earnings HeadlinesNashville police: Officer fatally shot armed man on Hermitage AvenueJune 11, 2025 | msn.comHole in road discovered: Northbound Colerain Avenue reduced to one lane near I-275June 11, 2025 | msn.comChaotic markets? No worries!As you may have seen over the last few weeks, I've been giving out special daily setups on my favorite ticker. We’ve been taking these setups @ 10AM and so far, we've posted 28 different payouts … Each of which were delivered at exactly 4PM as the market closed. You see, these setups require zero oversight and have shown the power to deliver in the most chaotic market conditions. And after a few weeks of fine-tuning … I knew it was time to let you in on The 4 PM Payout Plan. That's why Jack Carter and I pulled back the curtain to reveal how we've been able to nail in a 96% win rate in the same window the market lost 11 trillion dollars in value. | WealthPress (Ad)Bedford man jailed after Spencer man stabbed in Kirkwood Avenue alley in BloomingtonJune 11, 2025 | yahoo.comWater main break closes portion of Georgia AvenueJune 11, 2025 | msn.comTo combat perceived and true safety risks, Green Bay looks to Western Avenue as a hyperlocal modelJune 10, 2025 | msn.comSee More Avenue Therapeutics Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Avenue Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Avenue Therapeutics and other key companies, straight to your email. Email Address About Avenue TherapeuticsAvenue Therapeutics (NASDAQ:ATXI), a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida.View Avenue Therapeutics ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Smith & Wesson Stock Falls on Earnings Miss, Tariff WoesWhat to Expect From the Q2 Earnings Reporting CycleBroadcom Slides on Solid Earnings, AI Outlook Still StrongFive Below Pops on Strong Earnings, But Rally May StallRed Robin's Comeback: Q1 Earnings Spark Investor HopesOllie’s Q1 Earnings: The Good, the Bad, and What’s NextBroadcom Earnings Preview: AVGO Stock Near Record Highs Upcoming Earnings Bank of America (7/14/2025)Interactive Brokers Group (7/15/2025)America Movil (7/15/2025)Bank of New York Mellon (7/15/2025)Citigroup (7/15/2025)JPMorgan Chase & Co. (7/15/2025)Progressive (7/15/2025)Charles Schwab (7/15/2025)UnitedHealth Group (7/15/2025)Wells Fargo & Company (7/15/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
